Michelson Diagnostics begins development of in vivo OCT probes

March 17, 2008, St. Petersburg, FL--Michelson Diagnostics Ltd. (MDL; Orpington, England) announced at the OSA Biomed meeting here that it has commenced the engineering phase of development of probes for in vivo imaging with optical coherence tomography (OCT).

According to MDL Applications Director Dr. Gordon McKenzie, more than one type of probe will start clinical testing during 2008, although initially the company is targeting oral cancer. The probes will be suitable for a variety of applications, including research into diagnosis, treatment and monitoring of cancer of the oral cavity, esophagus, skin, cervix, colorectal tract, and lung.

"All of the probes will use MDL's breakthrough multi-beam OCT technology, which will provide at least double the resolution of competing equipment, for much crisper, clearer image of clinical features." The probes will be connected to an external diode-laser source via a fiberoptic cable.

Dr McKenzie confirmed that users of the existing EX1301 OCT Microscope will easily be able to upgrade to the in-vivo technology as soon as it is released. He also said that MDL is interested in finding clinical teams that are interested in conducting clinical trials with the in-vivo probes.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

NIR spectroscopy intravascular imaging system receives $25M investment

Medical device maker Infraredx has received a $25 million equity investment from Nipro Corporation, which builds on an exclusive agreement between the two companies for distribution of Infraredx's ...

OCT pioneer Fujimoto selected as 2014 IEEE Photonics Award winner

James Fujimoto, the Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (MIT), has been selected for the 2014 IEEE Photonics Award.

OCT combo system receives FDA clearance, begins shipping worldwide

Ophthalmic device maker Optovue has received FDA 510(k) clearance for its iFusion combination system, which pairs the company's iVue spectral-domain optical coherence tomography (SD-OCT) system and...

OCT symposium emphasizes key applications

Overviews of biomedical imaging in general, and optical coherence tomography (OCT) in particular, kicked off the first international symposium hosted last week by the Center for Biomedical OCT Rese...

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS